The KRAS c.35G>A, p.(Gly12Asp) variant leads to constitutive overactivation and increased signal transduction into downstream pathways and is associated with overgrowth including various types of congenital nevi and vascular malformations (so-called mosaic RASopathies) (32, 33). The gene discussed is KRAS; the disease is RASopathy.